CONTINUAL MERCAPTOPURINE FOLLOWED BY CONTINUAL CYTOSINE ARABINOSIDE IN LEUKEMIA

持续使用巯嘌呤治疗白血病，然后持续使用阿糖胞苷

• 批准号: 6244707
• 负责人: RAYMOND J HUTCHINSON
• 金额: $ 2.22万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-02-20 至 1997-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6244707
• 关键词: 6 thiopurine; child (0-11); clinical research; clinical trials; combination cancer therapy; cytosine arabinoside; drug screening /evaluation; human subject; human therapy evaluation; leukemia; neoplasm /cancer chemotherapy; pediatric neoplasm /cancer; pediatric pharmacology

This study was prepared by the Children's Cancer Group, which is a national group of physicians, nurses, and other specialists devoted to the study of childhood cancer. This program involves treatment with a new combination of anti-cancer drugs (chemotherapy).

这项研究是由儿童癌症组织准备的， 由医生、护士和其他专家组成的全国性组织，致力于 儿童癌症的研究。 该计划涉及治疗与 新的抗癌药物组合（化疗）。